EQIX vs IKT · P/E 79, rev $5.07B vs $215.2M cap
Equinix Inc (EQIX) versus Inhibikase Therapeutics Inc (IKT) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. IKT currently screens at market cap $215.2M.
Not investment advice. Open the EQIX and IKT stock pages for the full models.
Not investment advice.